BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Angadi PV, Krishnapillai R. Cyclin D1 expression in oral squamous cell carcinoma and verrucous carcinoma: correlation with histological differentiation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:e30-e35. [PMID: 17197212 DOI: 10.1016/j.tripleo.2006.09.011] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Tarle M, Raguž M, Muller D, Lukšić I. Nuclear Epidermal Growth Factor Receptor Overexpression as a Survival Predictor in Oral Squamous Cell Carcinoma. Int J Mol Sci 2023;24:5816. [PMID: 36982894 DOI: 10.3390/ijms24065816] [Reference Citation Analysis]
2 John RR, Sam N, Chandrasekaran B. Prognostic Significance of Proliferative Markers: Cyclin D1 and CENPF in Oral Squamous Cell Carcinoma Patients—A Cohort Study. J Maxillofac Oral Surg 2023. [DOI: 10.1007/s12663-023-01884-w] [Reference Citation Analysis]
3 Zhang J, Wu J, Chen Y, Zhang W. Dlx5 promotes cancer progression through regulation of CCND1 in oral squamous cell carcinoma (OSCC). Biochem Cell Biol 2021;99:424-34. [PMID: 34283652 DOI: 10.1139/bcb-2020-0523] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Kordbacheh F, Farah CS. Molecular Pathways and Druggable Targets in Head and Neck Squamous Cell Carcinoma. Cancers (Basel) 2021;13:3453. [PMID: 34298667 DOI: 10.3390/cancers13143453] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Chinnathambi PS, Kumar B D. Immunoexpression of cyclin d1 in head and neck squamous cell carcinomas – Correlation with histopathological grade and clinical parameters. JDPO 2021;6:99-104. [DOI: 10.18231/j.jdpo.2021.022] [Reference Citation Analysis]
6 Siril YJ, Kouketsu A, Saito H, Takahashi T, Kumamoto H. Immunohistochemical expression levels of cyclin D1 and CREPT reflect the course and prognosis in oral precancerous lesions and squamous cell carcinoma. Int J Oral Maxillofac Surg 2021:S0901-5027(21)00107-7. [PMID: 33838964 DOI: 10.1016/j.ijom.2021.03.012] [Reference Citation Analysis]
7 Naqvi AZ, Mahjabeen I, Ameen S, Ahmed MW, Khan AU, Akram Z, Kayani MA. Genetic and expression variations of cell cycle pathway genes in brain tumor patients. Biosci Rep 2020;40:BSR20190629. [PMID: 32373934 DOI: 10.1042/BSR20190629] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Panta P, Manavathi B, Nagini S. Genetics and Molecular Mechanisms in Oral Cancer Progression. Oral Cancer Detection 2019. [DOI: 10.1007/978-3-319-61255-3_2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 John RR, Ravindran C, Malathi N, Aruna RM. Evaluation of the Role Played by Cyclin D1 as a Diagnostic and Prognostic Marker in the Progression of Oral Carcinogenesis. J Maxillofac Oral Surg 2018;17:389-95. [PMID: 30034160 DOI: 10.1007/s12663-018-1087-2] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 Ramos-García P, González-Moles MÁ, González-Ruiz L, Ruiz-Ávila I, Ayén Á, Gil-Montoya JA. Prognostic and clinicopathological significance of cyclin D1 expression in oral squamous cell carcinoma: A systematic review and meta-analysis. Oral Oncol 2018;83:96-106. [PMID: 30098785 DOI: 10.1016/j.oraloncology.2018.06.007] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 6.2] [Reference Citation Analysis]
11 D'souza W, Saranath D. OMICS, Oral Cancer Molecular Landscapes, and Clinical Practice. OMICS: A Journal of Integrative Biology 2017;21:689-703. [DOI: 10.1089/omi.2017.0146] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
12 Patel SB, Manjunatha BS, Shah V, Soni N, Sutariya R. Immunohistochemical evaluation of p63 and cyclin D1 in oral squamous cell carcinoma and leukoplakia. J Korean Assoc Oral Maxillofac Surg 2017;43:324-30. [PMID: 29142867 DOI: 10.5125/jkaoms.2017.43.5.324] [Reference Citation Analysis]
13 Harishankar MK, Mohan AM, Krishnan AV, Devi A. Downregulation of Notch4 - a prognostic marker in distinguishing oral verrucous carcinoma from oral squamous cell carcinoma. Braz J Otorhinolaryngol 2019;85:11-6. [PMID: 29162408 DOI: 10.1016/j.bjorl.2017.09.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
14 Patel SB, Manjunatha BS, Shah V, Soni N, Sutariya R. Immunohistochemical evaluation of p63 and cyclin D1 in oral squamous cell carcinoma and leukoplakia. J Korean Assoc Oral Maxillofac Surg 2017;43:324-30. [PMID: 29142867 DOI: 10.5125/jkaoms.2017.43.5.324] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
15 Jia L, Wang J, Wu T, Wu J, Ling J, Cheng B. In vitro and in vivo antitumor effects of chloroquine on oral squamous cell carcinoma. Mol Med Rep 2017;16:5779-86. [PMID: 28849182 DOI: 10.3892/mmr.2017.7342] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
16 Silva LP, Gonzaga AKG, Serpa MS, Nascimento GJF, Sobral APV. Immunohistochemical expression of cyclooxygenase-2 and cyclin-D1 in oral squamous cell carcinoma. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology 2017;29:377-82. [DOI: 10.1016/j.ajoms.2016.12.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
17 Deng Z, Wang Y, Fang X, Yan F, Pan H, Gu L, Xie C, Li Y, Hu Y, Cao Y, Tang Z. Research on miRNA-195 and target gene CDK6 in oral verrucous carcinoma. Cancer Gene Ther 2017;24:282-8. [PMID: 28621315 DOI: 10.1038/cgt.2017.18] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
18 Ramos-garcía P, Gil-montoya J, Scully C, Ayén A, González-ruiz L, Navarro-triviño F, González-moles M. An update on the implications of cyclin D1 in oral carcinogenesis. Oral Dis 2017;23:897-912. [DOI: 10.1111/odi.12620] [Cited by in Crossref: 55] [Cited by in F6Publishing: 64] [Article Influence: 9.2] [Reference Citation Analysis]
19 Manimaran A, Buddhan R, Manoharan S. EMODIN DOWNREGULATES CELL PROLIFERATION MARKERS DURING DMBA INDUCED ORAL CARCINOGENESIS IN GOLDEN SYRIAN HAMSTERS. Afr J Tradit Complement Altern Med 2017;14:83-91. [PMID: 28573225 DOI: 10.21010/ajtcam.v14i2.10] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
20 Giuliano A, Swift R, Arthurs C, Marote G, Abramo F, McKay J, Thomson C, Beltran M, Millar M, Priestnall S, Dobson J, Costantino-Casas F, Petrou T, McGonnell IM, Davies AJ, Weetman M, Garden OA, Masters JR, Thrasivoulou C, Ahmed A. Quantitative Expression and Co-Localization of Wnt Signalling Related Proteins in Feline Squamous Cell Carcinoma. PLoS One 2016;11:e0161103. [PMID: 27559731 DOI: 10.1371/journal.pone.0161103] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
21 Mallick S, Breta M, Gupta SD, Dinda AK, Mohanty BK, Singh MK. Angiogenesis, Proliferative Activity and DNA Ploidy in Oral Verrucous Carcinoma: A Comparative Study Including Verrucous Hyperplasia and Squamous Cell Carcinoma. Pathol Oncol Res 2015;21:1249-57. [DOI: 10.1007/s12253-014-9856-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
22 Xu H, Xu B, Wang Z, Tan G, Shen S. Inhibition of Wnt/β-catenin signal is alleviated reactive gliosis in rats with hydrocephalus. Childs Nerv Syst 2015;31:227-34. [PMID: 25564198 DOI: 10.1007/s00381-014-2613-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
23 Basnaker M, Sp S, Bnvs S. Cyclin d1 gene expression in oral mucosa of tobacco chewers"-an immunohistochemical study. J Clin Diagn Res 2014;8:ZC70-5. [PMID: 24995250 DOI: 10.7860/JCDR/2014/9456.4406] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
24 Shen Y, Xu J, Jin J, Tang H, Liang J. Cyclin D1 expression in Bowen's disease and cutaneous squamous cell carcinoma. Mol Clin Oncol 2014;2:545-8. [PMID: 24940492 DOI: 10.3892/mco.2014.273] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
25 Ohnishi Y, Watanabe M, Wato M, Tanaka A, Kakudo K, Nozaki M. Cyclin D1 expression is correlated with cell differentiation and cell proliferation in oral squamous cell carcinomas. Oncol Lett 2014;7:1123-7. [PMID: 24944679 DOI: 10.3892/ol.2014.1880] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
26 Bologna-Molina R, Bedoya-Borella AM, Soria-Moreira L, Soría-Suárez S. Molecular biomarkers of cell proliferation in ameloblastomas. World J Stomatol 2013; 2(4): 79-85 [DOI: 10.5321/wjs.v2.i4.79] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
27 Hanken H, Gröbe A, Cachovan G, Smeets R, Simon R, Sauter G, Heiland M, Blessmann M. CCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carcinomas. Clin Oral Investig 2014;18:269-76. [PMID: 23494454 DOI: 10.1007/s00784-013-0967-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
28 Blessmann M, Al-Dam A, Hanken H, Assaf AT, Riecke B, Klatt J, Simon R, Sauter G, Heiland M, Kluwe L, Gröbe A. Amplification of the PPFIA1 gene region on 11q13 in oral squamous cell carcinomas (OSCC). J Craniomaxillofac Surg 2013;41:845-9. [PMID: 23453270 DOI: 10.1016/j.jcms.2013.01.040] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
29 Sintara K, Thong-Ngam D, Patumraj S, Klaikeaw N. Curcumin attenuates gastric cancer induced by N-methyl-N-nitrosourea and saturated sodium chloride in rats. J Biomed Biotechnol 2012;2012:915380. [PMID: 22690125 DOI: 10.1155/2012/915380] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
30 Saawarn S, Astekar M, Saawarn N, Dhakar N, Gomateshwar Sagari S. Cyclin d1 expression and its correlation with histopathological differentiation in oral squamous cell carcinoma. ScientificWorldJournal 2012;2012:978327. [PMID: 22629227 DOI: 10.1100/2012/978327] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
31 Pathare SM, Gerstung M, Beerenwinkel N, Schäffer AA, Kannan S, Pai P, Pathak KA, Borges AM, Mahimkar MB. Clinicopathological and prognostic implications of genetic alterations in oral cancers. Oncol Lett 2011;2:445-51. [PMID: 21546976 DOI: 10.3892/ol.2011.271] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
32 Kaminagakura E, Werneck da Cunha I, Soares FA, Nishimoto IN, Kowalski LP. CCND1 amplification and protein overexpression in oral squamous cell carcinoma of young patients. Head Neck 2011;33:1413-9. [DOI: 10.1002/hed.21618] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
33 Zargaran M, Eshghyar N, Vaziri PB, Mortazavi H. Immunohistochemical evaluation of type IV collagen and laminin-332 γ2 chain expression in well-differentiated oral squamous cell carcinoma and oral verrucous carcinoma: a new recommended cut-off: Immunostaining in OSCC and OVC. Journal of Oral Pathology & Medicine 2011;40:167-73. [DOI: 10.1111/j.1600-0714.2010.00983.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
34 Kuyama K, Matsumoto T, Fusi Fifita S, Sun Y, Morikawa M, Kato T, Yamamoto H. Cytological analysis of oral mucosal exophytic lesion. J Jpn Soc Clin Cytol 2010;49:177-184. [DOI: 10.5795/jjscc.49.177] [Reference Citation Analysis]
35 Ferrazzo KL, Neto MM, dos Santos E, dos Santos Pinto D, de Sousa SOM. Differential expression of galectin-3, β-catenin, and cyclin D1 in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands. Journal of Oral Pathology & Medicine 2009;38:701-7. [DOI: 10.1111/j.1600-0714.2009.00776.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]